Biochemical markers in the diagnostics of cardiovascular toxicity of hematooncology treatment in year 2008

Abstract

The paper deals with biochemical markers in the diagnostics of cardiovascular toxicity of hematooncology treatment. Glycogen phosphorylase BB (GPBB) could be a new circulating biomarker for the early detection of cardiotoxicity in hematooncology.

Keywords

• cardiovascular toxicity
• biochemical markers
• GPBB
• H-FABP
• chemotherapy